Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;45(1):21-30.
doi: 10.1055/s-0043-1763493. Epub 2023 Mar 6.

Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study

Julio Cesar Teixeira  1 , Diama Bhadra Vale  1 , Michelle Garcia Discacciati  1 , Cirbia Silva Campos  1 , Joana Froes Bragança  1 , Luiz Carlos Zeferino  1
Affiliations

Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study

Julio Cesar Teixeira et al. Rev Bras Ginecol Obstet. 2023 Jan.

Abstract
in English, Portuguese

Objective: To evaluate the rates of precancerous lesions, colposcopy referral, and positive predictive value (PPV) by age groups of a population-based screening with DNA-HPV testing.

Methods: The present demonstration study compared 16,384 HPV tests performed in the first 30 months of the program with 19,992 women tested in the cytology screening. The colposcopy referral rate and PPV for CIN2+ and CIN3+ by age group and screening program were compared. The statistical analysis used the chi-squared test and odds ratio (OR) with 95% confidence interval (95%CI).

Results: The HPV tests were 3.26% positive for HPV16-HPV18 and 9.92% positive for 12 other HPVs with a 3.7 times higher colposcopy referral rate than the cytology program, which had 1.68% abnormalities. Human Papillomavirus testing detected 103 CIN2, 89 CIN3, and one AIS, compared with 24 CIN2 and 54 CIN3 detected by cytology (p < 0.0001). The age group between 25 and 29 years old screened by HPV testing had 2.4 to 3.0 times more positivity, 13.0% colposcopy referral, twice more than women aged 30 to 39 years old (7.7%; p < 0.0001), and detected 20 CIN3 and 3 early-stage cancer versus 9 CIN3 and no cancer by cytology screening (CIN3 OR= 2.10; 95%CI: 0.91-5.25; p = 0.043). The PPV of colposcopy for CIN2+ ranged from 29.5 to 41.0% in the HPV testing program.

Conclusion: There was a significant increase in detections of cervix precancerous lesions in a short period of screening with HPV testing. In women < 30 years old, the HPV testing exhibited more positivity, high colposcopy referral rate, similar colposcopy PPV to older women, and more detection of HSIL and early-stage cervical cancer.

Objetivo: Avaliar as taxas de lesões pré-cancerosas, encaminhamento para colposcopia e valor preditivo positivo (VPP) por faixas etárias de rastreamento populacional com teste DNA-HPV. MéTODOS: O presente estudo de demonstração comparou 16.384 testes de HPV realizados nos primeiros 30 meses do programa com 19.992 mulheres testadas no rastreio citológico. Os programas foram comparados por taxa de encaminhamento de colposcopia e VPP para NIC2+ e NIC3+ por faixa etária. A análise estatística utilizou o teste de qui-quadrado e odds ratio (OR, na sigla em inglês) com intervalo de confiança (IC) de 95%.

Resultados: Os testes de HPV foram 3,26% positivos para HPV16-HPV18 e 9,92% positivos para 12 outros HPVs, com uma taxa de encaminhamento de colposcopia 3,7 vezes maior do que o programa de citologia, que teve 1,68% de anormalidades. O teste de HPV detectou 103 NIC2, 89 NIC3 e um AIS, em comparação com 24 NIC2 e 54 NIC3 detectados por citologia (p < 0,0001). O rastreio por teste de HPV no grupo etário 25 a 29 anos teve 2,4 a 3,0 vezes mais positividade, 13,0% de encaminhamento para colposcopia, 2 vezes mais que mulheres de 30 a 39 anos (7,7%; p < 0,0001), e detectou 20 NIC3 e 3 cânceres em estágio inicial versus nove NIC3 e nenhum câncer pelo rastreio citológico (NIC3 OR= 2,10; 96%CI: 0,91–5,25; p = 0,043). O VPP da colposcopia para NIC2+ variou de 29,5 a 41,0% no programa de teste de HPV. CONCLUSãO: Houve um aumento significativo na detecção de lesões pré-cancerosas do colo do útero em um curto período de rastreamento com teste de HPV. Em mulheres < 30 anos, o teste de HPV exibiu mais positividade, alta taxa de encaminhamento para colposcopia com VPP semelhante a mulheres mais velhas, e mais detecção de HSIL e de câncer cervical em estágio inicial.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests to declare.

References

    1. Instituto Nacional de Câncer Jose Alencar Gomes da Silva [Estimate 2020: cancer incidence in Brazil] [Internet] Rio de Janeiro: INCA; 2019[cited 2021 Jun 22]. Available from:https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//...
    1. Instituto Nacional de Câncer Jose Alencar Gomes da Silva [Brazilian cervical cancer screening guidelines] [Internet] 2a ed.Rio de Janeiro: INCA; 2016[cited 2021 Jun 22]. Available from:https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//...
    1. Freitas R A, Carvasan G A, Morais S S, Zeferino L C. Excessive Pap smears due to opportunistic cervical cancer screening. Eur J Gynaecol Oncol. 2008;29(05):479–482. - PubMed
    1. Teixeira J C, Maestri C A, Machado H DC, Zeferino L C, Carvalho N S. Cervical cancer registered in two developed regions from Brazil: upper limit of reachable results from opportunistic screening. Rev Bras Ginecol Obstet. 2018;40(06):347–353. doi: 10.1055/s-0038-1660841. - DOI - PMC - PubMed
    1. Vale D B, Menin T L, Bragança J F, Teixeira J C, Cavalcante L A, Zeferino L C. Estimating the public health impact of a national guideline on cervical cancer screening: an audit study of a program in Campinas, Brazil. BMC Public Health. 2019;19(01):1492. doi: 10.1186/s12889-019-7846-2. - DOI - PMC - PubMed